Chandra Bhagat Pharma Ltd. engages in the business of marketing pharmaceutical critical care & health care products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2020-02-14. The firm is engaged in the business of marketing pharmaceutical formulation and products in domestic and international markets through its distribution network and sales force under its own brand. The company is also engaged in the business of marketing pharmaceutical critical care & health care products. The company offers a wide range of product portfolio of pharmaceutical formulation including intravenous (IV) & intramuscular (IM) range injections, and a few tablets to cater the domestic & export market. The company has established presence in major therapeutic categories for formulations such as anticancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, neurology etc. The company is engaged in promoting and marketing of active pharmaceuticals ingredients (API's) in India.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.